http://www.ambergen.com/wp-content/uploads/logo-retina.png 0 0 Kenneth Rothschild http://www.ambergen.com/wp-content/uploads/logo-retina.png Kenneth Rothschild2014-12-27 13:37:452016-11-10 12:44:44AmberGen receives US Patent 8,906,700 providing broad coverage on PC-PURE™ technology for biomarker isolation and use in highly sensitive and quantitative assays
Get in Touch
313 Pleasant St.
Watertown, MA 02472
- AmberGen receives US Patent 9,910,034 increasing its broad coverage on PC-PURE™ photo-affinity biomarker purification and enrichment technology for improving the accuracy of diagnostic testing March 2018
- Paper published in PLOS ONE in collaboration with Boston Children’s Hospital “Photocleavage-based affinity purification of biomarkers from serum: Application to multiplex allergy testing” describing application of AmberGen’s PC-PURE™ to highly multiplex in vitro allergy testing (AllerBead™) February 2018